These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 23827472)

  • 1. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lysophosphatidylcholine on the plasminogen activator system in cultured vascular smooth muscle cells.
    Yoon BK; Kang YH; Oh WJ; Park K; Lee DY; Choi D; Kim DK; Lee Y; Rhyu MR
    J Korean Med Sci; 2012 Jul; 27(7):803-10. PubMed ID: 22787379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Black cohosh (Cimicifuga racemosa) relaxes the isolated rat thoracic aorta through endothelium-dependent and -independent mechanisms.
    Kim EY; Lee YJ; Rhyu MR
    J Ethnopharmacol; 2011 Nov; 138(2):537-42. PubMed ID: 22001858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
    Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
    J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 17β-Estradiol on the Plasminogen Activator System in Vascular Smooth Muscle Cells Treated with Lysophophatidylcholine.
    Yoon BK; Kang YH; Oh WJ; Lee DY; Kim DK; Kessel B; Kang CD
    J Menopausal Med; 2020 Apr; 26(1):9-17. PubMed ID: 32307945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
    Ramsby ML; Kreutzer DL
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
    van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
    Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor.
    Burdette JE; Liu J; Chen SN; Fabricant DS; Piersen CE; Barker EL; Pezzuto JM; Mesecar A; Van Breemen RB; Farnsworth NR; Bolton JL
    J Agric Food Chem; 2003 Sep; 51(19):5661-70. PubMed ID: 12952416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture.
    Pandolfi A; Iacoviello L; Capani F; Vitacolonna E; Donati MB; Consoli A
    Diabetologia; 1996 Dec; 39(12):1425-31. PubMed ID: 8960822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery.
    Zhang WJ; Wojta J; Binder BR
    Cell Mol Biol (Noisy-le-grand); 1997 Jun; 43(4):581-7. PubMed ID: 9220151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
    Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
    Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
    Diamond MP; Kruger M; Saed GM
    Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of plasminogen activator system in a rat model of periodontal wound healing.
    Xiao Y; Li H; Bunn C; Bartold PM
    J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes.
    Marutsuka K; Woodcock-Mitchell J; Sakamoto T; Sobel BE; Fujii S
    Coron Artery Dis; 1998; 9(4):177-84. PubMed ID: 9649923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.